Yıl: 2021 Cilt: 19 Sayı: 2 Sayfa Aralığı: 139 - 144 Metin Dili: İngilizce İndeks Tarihi: 18-11-2022

Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement

Öz:
Aim: Measurement of cardiac troponins is of great importance in the diagnosis and follow-up of acute myocardial infarction. The diagnostic specificity of myocardial infarction has increased with algorithms including serial troponin measurements. It is important that the measurements in the troponin cut-off values used to evaluate the risk of myocardial infarction in algorithms are reliable. In this study, it was aimed to evaluate the effect of hemolysis on clinical decision concentrations of the high sensitive cardiac troponin I (hs cTnI) test. Material and Methods: Two pools were created from serum samples with the 99th percentile upper reference value (17.5 ng/L) of hs cTnI and the high-risk cut-off value (50 ng/L) as specified in the European Society of Cardiology 2020 manual. Hemolysate was spiked in both pools with a hemolysis index of 100 to 1000. The hs cTnI levels in hemolysate-added sera were measured in Beckman Coulter UniCel Dxl 800 immunoassay device. Levels of hemolysis were calculated as percentage change. Results: Due to hemolysis, hs cTnI values decreased in varying proportions from 3.8% to 20.4% at 99th percentile concentration; values decreased from 4.3% to 20.0% in high-risk cut-off concentration. Conclusions: In hemolyzed samples, hs cTnI values decrease, this decrease is not considered clinically significant until high hemolysis values. However, it should be kept in mind that a decrease that may occur even in a low hemolysis may lead to erroneous evaluations in clinical decision concentrations.
Anahtar Kelime:

Beckman Coulter Yüksek Duyarlıklı Kardiyak Troponin I Ölçümü Üzerine Hemolizin Etkisi

Öz:
Amaç: Kardiyak troponinlerin ölçümü akut miyokard enfarktüsünün tan ı ve takibinde büyük önem taşımaktadırlar. Seri troponin ölçümlerinin yer ald ığı algoritmalar ile miyokard enfarktüs tan ısının spesifisitesi artmıştır. Algoritmalarda, miyokard enfarktüs riskini değerlendirmede yer alan troponin cut- off de ğerlerindeki ölçümlerin güvenilir olmas ı önemlidir. Bu çal ışmada, yüksek duyarl ıklı kardiyak troponin I (hs cTnI) testinin klinik karar konsantrasyonları üzerine hemolizin etkisini de ğerlendirmek amaçlandı. Gereç ve Yöntem: Serum örneklerinden, hs cTnI’nin 99. persentil üst referans değeri (17.5 ng/L) ve Avrupa Kardiyoloji Derne ği 2020 k ılavuzunda belirtilen yüksek-risk cut-off de ğeri (50 ng/L) olacak şekilde iki havuz olu şturuldu. Her iki havuza hemoliz indeksi 100’den 1000’e kadar olacak şekilde hemolizat eklendi. Hemolizat eklenmi ş serumlarda hs cTnI düzeyleri Beckman Coulter UniCel Dxl 800 immünoassay cihazında ölçüldü. Hemolizden etkilenme düzeyleri yüzde değişim olarak hesaplandı. Bulgular: Hemoliz nedeniyle hs cTnI değerleri, 99. persentil konsantrasyonunda %3.8’den %20.4’e; yüksek-risk cut-off konsantrasyonunda %4.3’ten %20’ye kadar değişen oranlarda azaldı. Sonuç: Hemolize örneklerde hs cTnI değerleri azal ır, bu azalma yüksek hemoliz de ğerlerine kadar klinik olarak anlamlı kabul edilmemektedir. Ancak düşük bir hemolizde bile olu şabilecek bir azalman ın klinik karar konsantrasyonlarında hatalı değerlendirmelere yol açabileceği unutulmamalıdır.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation 2020; 141(9):e139-e596.
  • 2. Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, deFilippi C, McCord J, et al. Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. Ann Emerg Med 2016;68(1):76-87 e4. İlanbey B. and Güçlü K. 144 Türk Klinik Biyokimya Derg 2021;19(2)
  • 3. Anderson JL, Morrow DA. Acute Myocardial Infarction. N Engl J Med 2017;376(21):2053-64.
  • 4. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019;40(3):237-69.
  • 5. Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 2020: ehaa575.
  • 6. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361(9):858-67.
  • 7. Lippi G, Cervellin G, Favaloro EJ, Plebani M. In vitro and in vivo hemolysis: an unresolved dispute in laboratory medicine: Walter De Gruyter; 2012.
  • 8. Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci 2011;48(3):143-53.
  • 9. Bais R. The effect of sample hemolysis on cardiac troponin I and T assays. Clin Chem 2010;56(8): 1357-9.
  • 10. Chenevier-Gobeaux C, Meune C, Blanc MC, Cynober L, Jaffray P, Lefevre G. Analytical evaluation of a high-sensitivity troponin T assay and its clinical assessment in acute coronary syndrome. Ann Clin Biochem 2011;48(Pt 5):452-8.
  • 11. Florkowski C, Wallace J, Walmsley T, George P. The effect of hemolysis on current troponin assays—a confounding preanalytical variable? Clin Chem 2010;56(7):1195-7.
  • 12. Hawkins RC. Hemolysis interference in the orthoclinical diagnostics vitros ECi cTnI assay. Clin Chem 2003;49(7):1226-7.
  • 13. Li A, Brattsand G. Stability of serum samples and hemolysis interference on the high sensitivity troponin T assay. Clin Chem Lab Med 2011; 49(2):335-6.
  • 14. Lippi G, Avanzini P, Dipalo M, Aloe R, Cervellin G. Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature. Clin Chem Lab Med 2011;49(12):2097-100.
  • 15. Ryan JB, Wallace J, Sies CW, Florkowski CM, George PM. Evaluation of Abbott Architect high-sensitivity troponin I assay for haemolysis interference. Pathology 2015;47(7):716-8.
  • 16. Meites S. Letter: Reproducibly simulating hemolysis, for evaluating its interference with chemical methods. Clin Chem 1973;19(11):1319.
  • 17. IFCC Committee on Clinical Applications of Cardiac Biomarkers (C-CB). Cardiac Troponin Assay Interference Table Designated by Manufacturer: Hemolysis and Biotin. v072020” https://www.ifcc.org/media/478590/cardiac-troponinassay-interference-table_v072020.pdf.
  • 18. NACB Writing Group; Wu AHB, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proBtype natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53(12):2086-96.
  • 19. Lippi G, Cadamuro J, von Meyer A, Simundic AM, European Federation of Clinical C, Laboratory Medicine Working Group for Preanalytical Phase (WG-PRE). Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med 2018;56(5):718-27.
  • 20. Cadamuro J, Lippi G, von Meyer A, Ibarz M, van Dongen E, Lases, et al. European survey on preanalytical sample handling - Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Biochem Med (Zagreb) 2019;29(2):020705.
  • 21. Luksic AH, Gabaj NN, Miler M, Dukic L, Bakliza A, Simundic AM. Visual assessment of hemolysis affects patient safety. Clin Chem Lab Med 2018;56(4):574- 81.
APA ilanbey B, GÜÇLÜ K (2021). Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. , 139 - 144.
Chicago ilanbey Bilal,GÜÇLÜ KENAN Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. (2021): 139 - 144.
MLA ilanbey Bilal,GÜÇLÜ KENAN Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. , 2021, ss.139 - 144.
AMA ilanbey B,GÜÇLÜ K Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. . 2021; 139 - 144.
Vancouver ilanbey B,GÜÇLÜ K Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. . 2021; 139 - 144.
IEEE ilanbey B,GÜÇLÜ K "Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement." , ss.139 - 144, 2021.
ISNAD ilanbey, Bilal - GÜÇLÜ, KENAN. "Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement". (2021), 139-144.
APA ilanbey B, GÜÇLÜ K (2021). Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. Türk Klinik Biyokimya Dergisi, 19(2), 139 - 144.
Chicago ilanbey Bilal,GÜÇLÜ KENAN Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. Türk Klinik Biyokimya Dergisi 19, no.2 (2021): 139 - 144.
MLA ilanbey Bilal,GÜÇLÜ KENAN Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. Türk Klinik Biyokimya Dergisi, vol.19, no.2, 2021, ss.139 - 144.
AMA ilanbey B,GÜÇLÜ K Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. Türk Klinik Biyokimya Dergisi. 2021; 19(2): 139 - 144.
Vancouver ilanbey B,GÜÇLÜ K Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement. Türk Klinik Biyokimya Dergisi. 2021; 19(2): 139 - 144.
IEEE ilanbey B,GÜÇLÜ K "Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement." Türk Klinik Biyokimya Dergisi, 19, ss.139 - 144, 2021.
ISNAD ilanbey, Bilal - GÜÇLÜ, KENAN. "Effect of Hemolysis on Beckman Coulter High Sensitive Cardiac Troponin I Measurement". Türk Klinik Biyokimya Dergisi 19/2 (2021), 139-144.